Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis
insights10marketing
58 views
64 slides
Aug 08, 2024
Slide 1 of 64
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
About This Presentation
This report presents a strategic analysis of the Hong Kong Artificial Intelligence (AI) in Diagnostics Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, cha...
Slide Content
Hong Kong Artificial
Intelligence (AI) in
DiagnosticsMarket
Analysis
Sample Report
July 2024
Intelligence (AI) in
DiagnosticsMarket
Analysis
Sample Report
July 2024
This report presents a strategic analysis of the Hong Kong Artificial
Intelligence (AI) in Diagnostics Market and a forecast for its
development in the medium and long term. It provides a comprehensive
overview of the market value, dynamics, segmentation, main players,
growth and demand drivers, challenges & future outlook, etc. This is
one of the most comprehensive reports about the Hong Kong Artificial
Intelligence (AI) in Diagnostics Market, and offers unmatched value,
accuracy, and expert insights.
Intelligence (AI) in Diagnostics Market and a forecast for its
development in the medium and long term. It provides a comprehensive
overview of the market value, dynamics, segmentation, main players,
growth and demand drivers, challenges & future outlook, etc. This is
one of the most comprehensive reports about the Hong Kong Artificial
Intelligence (AI) in Diagnostics Market, and offers unmatched value,
accuracy, and expert insights.
3 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Report Attribute Details
Number of Pages 60-70
Base Year for Estimation 2023
Forecast Period 2024-2030
Report Coverage
Market Overview, Size & Forecasting, Market Segmentation, Growth Factors and Trends, Competitive
Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement
Scenario
Quantitative Units Revenue in USD Million/Bn (Mn/Bn)
Currency Conversion 1 Euro = 1.08 USD
Research Approach Secondary Research (90%), Primary Research (10%)
Report Scope
Report Attribute Details
Number of Pages 60-70
Base Year for Estimation 2023
Forecast Period 2024-2030
Report Coverage
Market Overview, Size & Forecasting, Market Segmentation, Growth Factors and Trends, Competitive
Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement
Scenario
Quantitative Units Revenue in USD Million/Bn (Mn/Bn)
Currency Conversion 1 Euro = 1.08 USD
Research Approach Secondary Research (90%), Primary Research (10%)
Report Scope
4 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
CONTENT PG. NO.
1. Market Overview 07-15
1.1 Artificial Intelligence (AI) Overview
1.2 Artificial Intelligence (AI) in Diagnostics Overview: Global
1.3 Economic Overview: Hong Kong
1.4 Artificial Intelligence (AI) in Diagnostics Overview: Hong Kong
1.5 Healthcare Overview: Hong Kong
1.6 Budget of Hong Kong Government for Public Insurance
1.7 Top Developments in Hong Kong
2. AI in Diagnostics Landscape 16-18
2.1 Overview of Medical AI in Hong Kong
2.2 Use of Medical AI Software in Hong Kong
3. Market Size and Forecasting 19-24
3.1. Market Size and Forecasts (Excel and Methodology)
Table of Content
CONTENT PG. NO.
1. Market Overview 07-15
1.1 Artificial Intelligence (AI) Overview
1.2 Artificial Intelligence (AI) in Diagnostics Overview: Global
1.3 Economic Overview: Hong Kong
1.4 Artificial Intelligence (AI) in Diagnostics Overview: Hong Kong
1.5 Healthcare Overview: Hong Kong
1.6 Budget of Hong Kong Government for Public Insurance
1.7 Top Developments in Hong Kong
2. AI in Diagnostics Landscape 16-18
2.1 Overview of Medical AI in Hong Kong
2.2 Use of Medical AI Software in Hong Kong
3. Market Size and Forecasting 19-24
3.1. Market Size and Forecasts (Excel and Methodology)
Table of Content
5 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
CONTENT PG. NO.
3.2. Market Segmentation
3.2.1. Modality
3.2.2. Application
3.2.3. End User
4. Market Dynamics 25-30
4.1. Market Growth Drivers
4.2. Market Growth Restraints
5. Competitive Landscape 31-38
5.1. Key Players in Artificial Intelligence (AI) in Diagnostics Market
5.1.1. IBM
5.1.2. Siemens Healthineers
5.1.3. Philips Healthcare
5.1.4. GE Healthcare
Table of Content
CONTENT PG. NO.
3.2. Market Segmentation
3.2.1. Modality
3.2.2. Application
3.2.3. End User
4. Market Dynamics 25-30
4.1. Market Growth Drivers
4.2. Market Growth Restraints
5. Competitive Landscape 31-38
5.1. Key Players in Artificial Intelligence (AI) in Diagnostics Market
5.1.1. IBM
5.1.2. Siemens Healthineers
5.1.3. Philips Healthcare
5.1.4. GE Healthcare
Table of Content
6 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
CONTENT PG. NO.
5.1.5. AliveCor
5.1.6. Annalise.AI
5.1.7. Imsight Technology
5.1.8. Sense Time
5.1.9. Time Medical Systems
5.1.10. Subtle Medical
6. Regulatory and Reimbursement Landscape 39-43
6.1. Regulatory Landscape in Hong Kong
6.2. Reimbursement Scenario in Hong Kong
6.3. Reimbursement Process
Table of Content
CONTENT PG. NO.
5.1.5. AliveCor
5.1.6. Annalise.AI
5.1.7. Imsight Technology
5.1.8. Sense Time
5.1.9. Time Medical Systems
5.1.10. Subtle Medical
6. Regulatory and Reimbursement Landscape 39-43
6.1. Regulatory Landscape in Hong Kong
6.2. Reimbursement Scenario in Hong Kong
6.3. Reimbursement Process
Table of Content
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis Analysis
1. Market Overview
1. Market Overview
▪Artificial Intelligence (AI), is the simulation of human intelligence in machines, enabling
computers to perform tasks that typically require human cognition, such as decision-making,
problem-solving, and pattern recognition
▪AI is implemented in various aspects of healthcare such as enhancing diagnostic accuracy,
personalizing treatment plans, and streamlining administrative processes
▪Integration of AI in healthcare offers numerous benefits, including improved patient care, reduced
healthcare costs, and increased operational efficiency
AI in used diagnostics for several purposes , such as:
▪Analyze medical images (e.g., X-rays, MRIs, ultrasounds, CT scans, and DXAs)
▪Analyze bio-signals (e.g., ECG, EEG, EMG)
▪Analyze vital signs (e.g., body temperature, pulse rate, respiration rate, and blood pressure)
▪Detect infections from blood samples
1.1 Artificial Intelligence (AI) Overview
computers to perform tasks that typically require human cognition, such as decision-making,
problem-solving, and pattern recognition
▪AI is implemented in various aspects of healthcare such as enhancing diagnostic accuracy,
personalizing treatment plans, and streamlining administrative processes
▪Integration of AI in healthcare offers numerous benefits, including improved patient care, reduced
healthcare costs, and increased operational efficiency
AI in used diagnostics for several purposes , such as:
▪Analyze medical images (e.g., X-rays, MRIs, ultrasounds, CT scans, and DXAs)
▪Analyze bio-signals (e.g., ECG, EEG, EMG)
▪Analyze vital signs (e.g., body temperature, pulse rate, respiration rate, and blood pressure)
▪Detect infections from blood samples
1.1 Artificial Intelligence (AI) Overview
9 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
7.23
7.32
7.40
7.49
7.58
7.66
7.74
7.82
7.89
7.95
8.02
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
65+ Population in the World 2013-2023 (In Bn)
1.2 Artificial Intelligence (AI) in Diagnostics Overview: Global (1/2)
700+
AI-ML enabled medical
devices are currently
approved by US-FDA
43%
Patients have a limited
understanding of AI and its
use in healthcare
38%
Healthcare providers
globally are using AI in
diagnostics in 2023
60% +
Hospitals in the US have
integrated AI in the
healthcare delivery
process
7.23
7.32
7.40
7.49
7.58
7.66
7.74
7.82
7.89
7.95
8.02
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
65+ Population in the World 2013-2023 (In Bn)
1.2 Artificial Intelligence (AI) in Diagnostics Overview: Global (1/2)
700+
AI-ML enabled medical
devices are currently
approved by US-FDA
43%
Patients have a limited
understanding of AI and its
use in healthcare
38%
Healthcare providers
globally are using AI in
diagnostics in 2023
60% +
Hospitals in the US have
integrated AI in the
healthcare delivery
process
10 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Hong Kong
Market
~$xx Bn Market
Illustrative
1.2 Artificial Intelligence (AI) in Diagnostics Overview: Global (2/2)
Hong Kong
Market
~$xx Bn Market
Illustrative
1.2 Artificial Intelligence (AI) in Diagnostics Overview: Global (2/2)
11 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
2016 2017 2018 2019 2020 2021 2022 2023
Population of Hong Kong, (in Mn)
2016 2017 2018 2019 2020 2021 2022 2023
GDP of Hong Kong, (in $Bn)
Population Split (2023)
0-14
15-64
65+
By Age GroupBy Gender
▪Hong Kong is an aging country, as it’s median age is 45.9 years
which is higher than global median age
▪Hong Kong is the fourth most densely populated place globally
with a population of nearly 7.5 Mn people
▪Life expectancy of female is 86.8 years and for male it is 80.7
years
▪More than 90% of the population is urban
▪Its economy is dominated by the service sector which
contributes about 94% to the GDP
Illustrative
1.3 Economic Overview: Hong Kong
Male
Female
2016 2017 2018 2019 2020 2021 2022 2023
Population of Hong Kong, (in Mn)
2016 2017 2018 2019 2020 2021 2022 2023
GDP of Hong Kong, (in $Bn)
Population Split (2023)
0-14
15-64
65+
By Age GroupBy Gender
▪Hong Kong is an aging country, as it’s median age is 45.9 years
which is higher than global median age
▪Hong Kong is the fourth most densely populated place globally
with a population of nearly 7.5 Mn people
▪Life expectancy of female is 86.8 years and for male it is 80.7
years
▪More than 90% of the population is urban
▪Its economy is dominated by the service sector which
contributes about 94% to the GDP
Illustrative
1.3 Economic Overview: Hong Kong
Male
Female
12 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.4 Artificial Intelligence (AI) in Diagnostics Market Overview: Hong Kong
200+
AI-based enterprises
currently in Hong Kong
75%
Is the reduction in
administrative time owing to
AI in hospitals in Hong Kong
10+
Public hospitals in Hong
Kong have adopted AI in
hospital operation till 2023
$10,6215
Is the average investment
in AI in Hong Kong
AI Application Areas in Hong Kong (2023)
Healthcare
Education and Training
Manufacturing
Government Organizations
Information Technology
Illustrative
1.4 Artificial Intelligence (AI) in Diagnostics Market Overview: Hong Kong
200+
AI-based enterprises
currently in Hong Kong
75%
Is the reduction in
administrative time owing to
AI in hospitals in Hong Kong
10+
Public hospitals in Hong
Kong have adopted AI in
hospital operation till 2023
$10,6215
Is the average investment
in AI in Hong Kong
AI Application Areas in Hong Kong (2023)
Healthcare
Education and Training
Manufacturing
Government Organizations
Information Technology
Illustrative
13 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
1.5 Healthcare Overview: Hong Kong
Public Healthcare
▪Hong Kong's public healthcare has high-quality services
and accessibility, predominantly funded by the government
through taxation
▪Managed by the Hospital Authority, the system offers
comprehensive healthcare services across various
facilities, including 43 public hospitals, 49 specialist
outpatient clinics, and 73 general outpatient clinics
▪This healthcare model ensures that residents receive
affordable care, with nominal fees for services, and
focuses on a range of medical needs from emergency
care to chronic disease management
Private Healthcare
▪There are a number of private hospitals and medical
services provided by the private healthcare sector
▪In addition to 12 private hospitals, there are hundreds of
private outpatient facilities from neighborhood GPs, to
specialist clinics, diagnostic centers and laboratories
across Hong Kong.
▪Department of Health (DH) regulates licensed private
healthcare facilities under the Private Healthcare Facilities
Ordinance and medical clinics registered under the
Medical Clinics Ordinance
1.5 Healthcare Overview: Hong Kong
Public Healthcare
▪Hong Kong's public healthcare has high-quality services
and accessibility, predominantly funded by the government
through taxation
▪Managed by the Hospital Authority, the system offers
comprehensive healthcare services across various
facilities, including 43 public hospitals, 49 specialist
outpatient clinics, and 73 general outpatient clinics
▪This healthcare model ensures that residents receive
affordable care, with nominal fees for services, and
focuses on a range of medical needs from emergency
care to chronic disease management
Private Healthcare
▪There are a number of private hospitals and medical
services provided by the private healthcare sector
▪In addition to 12 private hospitals, there are hundreds of
private outpatient facilities from neighborhood GPs, to
specialist clinics, diagnostic centers and laboratories
across Hong Kong.
▪Department of Health (DH) regulates licensed private
healthcare facilities under the Private Healthcare Facilities
Ordinance and medical clinics registered under the
Medical Clinics Ordinance
14 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Medicare
$769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
As % Of GDP 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
▪National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE
▪Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE
▪Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE
▪Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE
▪Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020
▪Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020
▪Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020
▪Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending
accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
1.6 Budget of Hong Kong Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Medicare
$769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
As % Of GDP 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
▪National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE
▪Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE
▪Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE
▪Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE
▪Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020
▪Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020
▪Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020
▪Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending
accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
1.6 Budget of Hong Kong Government for Public Insurance
15 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Company Name Type Year Key Pointers
New Development 2024
▪Researchers from the Faculty of Medicine at the Chinese University of
Hong Kong (CU Medicine) have utilized anonymized big data from the
Hospital Authority Data Collaboration Laboratory to develop a new
machine learning model that can predict the risk of severe hypoglycemia
among older diabetic adults
▪Based on the XGBoost machine learning algorithm, the risk prediction
model uses 258 predictors, including demographics, admissions, and
diagnoses, to predict severe hypoglycemia events requiring
hospitalization in the next 12 months
New Development 2024
▪Developed by the Centre for Artificial Intelligence and Robotics (CAIR) of
the CAS Hong Kong Institute of Science and Innovation, the CARES
Copilot 1.0 model offers physicians enhanced accuracy in data retrieval. It
can generate information and citations from academic sources, with data
accuracy up to 95%
▪Using the AI model for complement surgery, image navigation, and
medical robotics in clinics, operating rooms and research institutes can
directly assist medical staff in dealing with emergencies
Latest Deals in Hong Kong
Illustrative
1.7 Top Developments in Hong Kong
Company Name Type Year Key Pointers
New Development 2024
▪Researchers from the Faculty of Medicine at the Chinese University of
Hong Kong (CU Medicine) have utilized anonymized big data from the
Hospital Authority Data Collaboration Laboratory to develop a new
machine learning model that can predict the risk of severe hypoglycemia
among older diabetic adults
▪Based on the XGBoost machine learning algorithm, the risk prediction
model uses 258 predictors, including demographics, admissions, and
diagnoses, to predict severe hypoglycemia events requiring
hospitalization in the next 12 months
New Development 2024
▪Developed by the Centre for Artificial Intelligence and Robotics (CAIR) of
the CAS Hong Kong Institute of Science and Innovation, the CARES
Copilot 1.0 model offers physicians enhanced accuracy in data retrieval. It
can generate information and citations from academic sources, with data
accuracy up to 95%
▪Using the AI model for complement surgery, image navigation, and
medical robotics in clinics, operating rooms and research institutes can
directly assist medical staff in dealing with emergencies
Latest Deals in Hong Kong
Illustrative
1.7 Top Developments in Hong Kong
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis Analysis
2. AI in Diagnostics Landscape
2. AI in Diagnostics Landscape
17 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
2.1 Overview of Medical AI in Hong Kong
▪Hong Kong government has implemented several initiatives such as the “AI for Good” which primarily focus on promoting AI research in
several industry areas including healthcare
▪It aims to make Hong Kong a global hub for AI research and development
▪Apart from global players and local start-ups, many universities and research institutes are innovating medical AI software for diagnostics
Top Universities in Hong Kong
for AI R&D
Key Development Areas
▪Medical Artificial Intelligence Lab Program (MAIL):
AI-based optical coherence tomography (OCT) retinal
disease screening and diagnosis system
▪AI virtual patients' diagnostic application:
Leveraging generative AI technology and real-life
surgical cases, allows medical students to virtually
simulate interactions
▪AIMED: Orthopedics intelligent PACS system
powered by AI techniques for instant disease
diagnosis, management and tracking
2.1 Overview of Medical AI in Hong Kong
▪Hong Kong government has implemented several initiatives such as the “AI for Good” which primarily focus on promoting AI research in
several industry areas including healthcare
▪It aims to make Hong Kong a global hub for AI research and development
▪Apart from global players and local start-ups, many universities and research institutes are innovating medical AI software for diagnostics
Top Universities in Hong Kong
for AI R&D
Key Development Areas
▪Medical Artificial Intelligence Lab Program (MAIL):
AI-based optical coherence tomography (OCT) retinal
disease screening and diagnosis system
▪AI virtual patients' diagnostic application:
Leveraging generative AI technology and real-life
surgical cases, allows medical students to virtually
simulate interactions
▪AIMED: Orthopedics intelligent PACS system
powered by AI techniques for instant disease
diagnosis, management and tracking
18 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
2.2 Use of Medical AI Software in Hong Kong
Public Hospitals Specialist Out-Patient
Clinics
General Out-Patient
Clinics
Private Hospitals
Healthcare Institutions in Hong Kong, (2023) Examples of Hospitals in Hong Kong Using Medical AI
▪Radiology department at Gleneagles Hong Kongwill be adopting
Australian company Annalise.ai's AI solution for analysing chest
X-rays and CT brain scans
Illustrative
2.2 Use of Medical AI Software in Hong Kong
Public Hospitals Specialist Out-Patient
Clinics
General Out-Patient
Clinics
Private Hospitals
Healthcare Institutions in Hong Kong, (2023) Examples of Hospitals in Hong Kong Using Medical AI
▪Radiology department at Gleneagles Hong Kongwill be adopting
Australian company Annalise.ai's AI solution for analysing chest
X-rays and CT brain scans
Illustrative
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis Analysis
3. Market Size and Forecasting
3. Market Size and Forecasting
20 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Forecast, 2023-2030
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient ($Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Hong Kong Patient Size ($Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size ($Bn) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Hong Kong Market Size ($Bn) 61 74 84 87 91 95 99 106
Illustrative
3.1 Hong Kong Artificial Intelligence (AI) in Diagnostics Market Size and
Forecasts
2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Forecast, 2023-2030
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient ($Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Hong Kong Patient Size ($Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size ($Bn) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Hong Kong Market Size ($Bn) 61 74 84 87 91 95 99 106
Illustrative
3.1 Hong Kong Artificial Intelligence (AI) in Diagnostics Market Size and
Forecasts
21 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
▪In this section you will get an understanding of the segmentations which will cover the Hong Kong Artificial Intelligence (AI) in Diagnostics
Market
▪In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Modality
CT-Scan
Magnetic Resonance Imaging
(MRI)
X-Ray
Ultrasound
Others
Application
Cardiology
Oncology
Pathology
Radiology
Others
End User
Hospitals
Labs
Illustrative
3.2 Snapshot of Hong Kong Artificial Intelligence (AI) in Diagnostics Market
Segmentation
▪In this section you will get an understanding of the segmentations which will cover the Hong Kong Artificial Intelligence (AI) in Diagnostics
Market
▪In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Modality
CT-Scan
Magnetic Resonance Imaging
(MRI)
X-Ray
Ultrasound
Others
Application
Cardiology
Oncology
Pathology
Radiology
Others
End User
Hospitals
Labs
Illustrative
3.2 Snapshot of Hong Kong Artificial Intelligence (AI) in Diagnostics Market
Segmentation
22 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis Share,
By Modality (2023)
CT-Scan
Magnetic
Resonance
Imaging (MRI)
Healthcare at
Home
X-Ray
Ultrasound
Others
Illustrative
3.2.1 Market Segmentation: By Modality
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis Share,
By Modality (2023)
CT-Scan
Magnetic
Resonance
Imaging (MRI)
Healthcare at
Home
X-Ray
Ultrasound
Others
Illustrative
3.2.1 Market Segmentation: By Modality
23 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis Share,
By Application (2023)
Cardiology
Oncology
Pathology
Radiology
Others
Illustrative
3.2.2 Market Segmentation: By Application
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis Share,
By Application (2023)
Cardiology
Oncology
Pathology
Radiology
Others
Illustrative
3.2.2 Market Segmentation: By Application
24 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis Share,
By End User (2023)
Hospitals
Labs
Illustrative
3.2.3 Market Segmentation: By End User
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis Share,
By End User (2023)
Hospitals
Labs
Illustrative
3.2.3 Market Segmentation: By End User
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis Analysis
4. Market Dynamics
4. Market Dynamics
26 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Illustrative
4.1.1
Steadily rising aging
population of ~25%
requiring early
detection and
diagnosis
4.1.2
Supportive
government
initiatives for AI
adoption in
healthcare
4.1.3
Increasing
investments in AI
enterprises promotes
development of new
technology
4.2.1
Data privacy and
safety concerns
4.2.2
High costs of
medical AI software
development and
implementation
4. Snapshot Of Market Growth Drivers And Restraints
Illustrative
4.1.1
Steadily rising aging
population of ~25%
requiring early
detection and
diagnosis
4.1.2
Supportive
government
initiatives for AI
adoption in
healthcare
4.1.3
Increasing
investments in AI
enterprises promotes
development of new
technology
4.2.1
Data privacy and
safety concerns
4.2.2
High costs of
medical AI software
development and
implementation
4. Snapshot Of Market Growth Drivers And Restraints
27 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Illustrative
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
4.1 Market Growth Drivers
4.1.1 Steadily rising aging population of approximately 25% requiring early detection and accurate diagnosis
Aging Demographic in Hong Kong, (in %)
2022 2024 2026 2028 2030
Illustrative
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
4.1 Market Growth Drivers
4.1.1 Steadily rising aging population of approximately 25% requiring early detection and accurate diagnosis
Aging Demographic in Hong Kong, (in %)
2022 2024 2026 2028 2030
28 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
4.1 Market Growth Drivers
4.1.2 Supportive government initiatives for AI adoption in healthcare
Initiatives Description
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
4.1 Market Growth Drivers
4.1.2 Supportive government initiatives for AI adoption in healthcare
Initiatives Description
29 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
4.1 Market Growth Drivers
4.1.3 Increasing investments averaging around $10,000 in AI enterprises promotes development of new technology
Increasing AI Investments in Hong Kong, (in $)
2020 2024 2028 2032
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
4.1 Market Growth Drivers
4.1.3 Increasing investments averaging around $10,000 in AI enterprises promotes development of new technology
Increasing AI Investments in Hong Kong, (in $)
2020 2024 2028 2032
30 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
4.2.1 Data privacy and safety concerns restricting the
collection of large amounts of medical data for AI training
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
4.2.2 High costs of medical AI software development and
implementation averaging at $100K
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative
4.2 Market Growth Restraints
4.2.1 Data privacy and safety concerns restricting the
collection of large amounts of medical data for AI training
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
4.2.2 High costs of medical AI software development and
implementation averaging at $100K
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative
4.2 Market Growth Restraints
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis Analysis
5. Competitive Landscape
5. Competitive Landscape
32 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
▪Here is the list of top 10 companies which
will cover in the final report
▪Each company will have slides for
oOverview
oKey details
oOfferings
oName of products
oRecent activities/ Press Coverage
oDistribution and Vendor Partners
oMergers, Acquisitions and
Collaboration
oFinancials
▪If there are specific companies that you
would like to be included in the report,
please let us know via email
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
IBM1 Annalise.AI6
Siemens Healthineers2 Imsight Technology7
Philips Healthcare3 Sense Time8
GE Healthcare4 Time Medical Systems9
AliveCor5 Subtle Medical10
Illustrative
Global Players Local Players
5.1 Key Players in Hong Kong Artificial Intelligence (AI) in Diagnostics Market
Analysis
▪Here is the list of top 10 companies which
will cover in the final report
▪Each company will have slides for
oOverview
oKey details
oOfferings
oName of products
oRecent activities/ Press Coverage
oDistribution and Vendor Partners
oMergers, Acquisitions and
Collaboration
oFinancials
▪If there are specific companies that you
would like to be included in the report,
please let us know via email
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
IBM1 Annalise.AI6
Siemens Healthineers2 Imsight Technology7
Philips Healthcare3 Sense Time8
GE Healthcare4 Time Medical Systems9
AliveCor5 Subtle Medical10
Illustrative
Global Players Local Players
5.1 Key Players in Hong Kong Artificial Intelligence (AI) in Diagnostics Market
Analysis
33 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Founded In: 1911
HQ: New York, United States
Type: Public
Revenue: $60.52 Bn (Global)
Website: www.ibm.com
▪IBM, a global tech leader with a presence in over 170 countries, is
at the forefront of innovation across various sectors
▪Beyond its traditional strengths in computing and IT, IBM is actively
leveraging its artificial intelligence (AI) expertise to revolutionize
healthcare
▪Its AI for healthcare initiatives focus on areas like early disease
detection, medical imaging analysis, and creating personalized
treatment plans, aiming to improve patient care and optimize
healthcare systems
Solution Offerings
➢Data and AI
➢Infrastructure
➢Security
➢Sustainability
AI in Diagnostics: IBM Watson
5.1.1 IBM
▪IBM Watson is an AI system developed by IBM capable of answering questions posed in natural language
▪In medical imaging and diagnostics, IBM Watson is used to enhance the accuracy and efficiency of healthcare services with the following key
applications
▪Uses AI algorithms to analyze X-
rays, MRIs, CT scans to detect
abnormalities like tumors, fractures,
and lesions
Watson Health Imaging
▪Analyzes genomic data to identify
mutations and variations specific to a
patient aiding in diagnosing the tumor
characteristics
Watson for Genomics
▪It is a tool that synthesizes data from
a patient’s medical history, clinical
reports, and imaging studies aiding in
the diagnostic process.
Watson Patient Synopsis
Founded In: 1911
HQ: New York, United States
Type: Public
Revenue: $60.52 Bn (Global)
Website: www.ibm.com
▪IBM, a global tech leader with a presence in over 170 countries, is
at the forefront of innovation across various sectors
▪Beyond its traditional strengths in computing and IT, IBM is actively
leveraging its artificial intelligence (AI) expertise to revolutionize
healthcare
▪Its AI for healthcare initiatives focus on areas like early disease
detection, medical imaging analysis, and creating personalized
treatment plans, aiming to improve patient care and optimize
healthcare systems
Solution Offerings
➢Data and AI
➢Infrastructure
➢Security
➢Sustainability
AI in Diagnostics: IBM Watson
5.1.1 IBM
▪IBM Watson is an AI system developed by IBM capable of answering questions posed in natural language
▪In medical imaging and diagnostics, IBM Watson is used to enhance the accuracy and efficiency of healthcare services with the following key
applications
▪Uses AI algorithms to analyze X-
rays, MRIs, CT scans to detect
abnormalities like tumors, fractures,
and lesions
Watson Health Imaging
▪Analyzes genomic data to identify
mutations and variations specific to a
patient aiding in diagnosing the tumor
characteristics
Watson for Genomics
▪It is a tool that synthesizes data from
a patient’s medical history, clinical
reports, and imaging studies aiding in
the diagnostic process.
Watson Patient Synopsis
34 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Company Name Type Year Key Pointers
Partnership 2024
▪IT services company HCL Technologies IBM announced a new
partnership to create a Generative AI Centre of Excellence
▪HCLTech plans to train 10,000 of its engineers and architects in IBM's AI
technologies, particularly 'watsonx’
▪This initiative aims to help enterprises modernize legacy applications,
develop IT service management use cases, reduce coding complexity,
enhance skill development on the watsonx platform, and foster
continuous innovation
Latest Deals in IBM
Illustrative
5.1.1 IBM (Continued)
Company Name Type Year Key Pointers
Partnership 2024
▪IT services company HCL Technologies IBM announced a new
partnership to create a Generative AI Centre of Excellence
▪HCLTech plans to train 10,000 of its engineers and architects in IBM's AI
technologies, particularly 'watsonx’
▪This initiative aims to help enterprises modernize legacy applications,
develop IT service management use cases, reduce coding complexity,
enhance skill development on the watsonx platform, and foster
continuous innovation
Latest Deals in IBM
Illustrative
5.1.1 IBM (Continued)
35 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2023
1 2 3 4
Illustrative
5.1.1 IBM (Continued)
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2023
1 2 3 4
Illustrative
5.1.1 IBM (Continued)
36 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Founded In:
HQ:
Type:
Revenue:
Website:
Offerings
Recent Activity / Press Coverage
5.1.2 Siemens Healthineers
Illustrative
Founded In:
HQ:
Type:
Revenue:
Website:
Offerings
Recent Activity / Press Coverage
5.1.2 Siemens Healthineers
Illustrative
37 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Company Name Type Year Key Pointers
Latest Deals in Siemens Healthineers
Illustrative
5.1.2 Siemens Healthineers (Continued)
Company Name Type Year Key Pointers
Latest Deals in Siemens Healthineers
Illustrative
5.1.2 Siemens Healthineers (Continued)
38 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2023
1 2 3 4
Illustrative
5.1.2 Siemens Healthineers (Continued)
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2023
1 2 3 4
Illustrative
5.1.2 Siemens Healthineers (Continued)
Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis Analysis
6. Regulatory and Reimbursement Landscape
6. Regulatory and Reimbursement Landscape
40 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
The Department of Health (DH) is the primary governmental body responsible for the health of the people and the overall healthcare system in
Hong Kong. Its key governmental agencies responsible for medical devices including those incorporating AI are as follows:
▪Medical Device Division (MDD), formerly known as the Medical Device Control Office (MDCO), is responsible for regulating the import,
export, manufacture, and sale of medical devices in Hong Kong. It ensures that medical devices meet safety, efficacy, and quality standards
▪Department of Health (DH), oversees public health services in Hong Kong, including the regulation of pharmaceuticals and medical
devices. It plays a crucial role in implementing health policies and ensuring public health safety ensuring that medical devices and AI
applications used in healthcare comply with relevant health standards and guidelines
▪Office of the Government Chief Information Officer (OGCIO), is responsible for the formulation and implementation of policies and
initiatives related to information technology in Hong Kong. It provides guidelines and frameworks for the adoption of emerging technologies,
including AI. It focuses on data privacy, cybersecurity, and ethical considerations in the deployment of AI solutions
▪Hong Kong Science and Technology Parks Corporation (HKSTP), supports innovation and technology development in Hong Kong by
providing infrastructure, funding, and policy support to startups and enterprises. It promotes the development and commercialization of AI
and medical technologies
▪Medical Device Administrative Control System (MDACS)), provides a framework for the classification, registration, and safety monitoring
of medical devices in Hong Kong
Illustrative
Regulatory Authorities With Jurisdiction Over Medical Devices and Artificial Intelligence (AI) In Hong Kong
6.1 Regulatory Landscape in Hong Kong
The Department of Health (DH) is the primary governmental body responsible for the health of the people and the overall healthcare system in
Hong Kong. Its key governmental agencies responsible for medical devices including those incorporating AI are as follows:
▪Medical Device Division (MDD), formerly known as the Medical Device Control Office (MDCO), is responsible for regulating the import,
export, manufacture, and sale of medical devices in Hong Kong. It ensures that medical devices meet safety, efficacy, and quality standards
▪Department of Health (DH), oversees public health services in Hong Kong, including the regulation of pharmaceuticals and medical
devices. It plays a crucial role in implementing health policies and ensuring public health safety ensuring that medical devices and AI
applications used in healthcare comply with relevant health standards and guidelines
▪Office of the Government Chief Information Officer (OGCIO), is responsible for the formulation and implementation of policies and
initiatives related to information technology in Hong Kong. It provides guidelines and frameworks for the adoption of emerging technologies,
including AI. It focuses on data privacy, cybersecurity, and ethical considerations in the deployment of AI solutions
▪Hong Kong Science and Technology Parks Corporation (HKSTP), supports innovation and technology development in Hong Kong by
providing infrastructure, funding, and policy support to startups and enterprises. It promotes the development and commercialization of AI
and medical technologies
▪Medical Device Administrative Control System (MDACS)), provides a framework for the classification, registration, and safety monitoring
of medical devices in Hong Kong
Illustrative
Regulatory Authorities With Jurisdiction Over Medical Devices and Artificial Intelligence (AI) In Hong Kong
6.1 Regulatory Landscape in Hong Kong
41 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
Public healthcare coverage is provided by the government and includes
programs like Medicare and Medicaid
Medicare is a federal program that provides healthcare coverage to individuals
who are 65 years of age or older, as well as certain younger people with
disabilities
▪Shift towards value-based care has been a significant trend in Hong Kong healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care
38.9% 37.1% 35.6% 32.5% 31.5%
44.0%
46.0% 47.7%
51.0% 51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx
xx xx
xx xx
2019 2020 2021 2022 2023
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative
6.2 Reimbursement Scenario in Hong Kong
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
Public healthcare coverage is provided by the government and includes
programs like Medicare and Medicaid
Medicare is a federal program that provides healthcare coverage to individuals
who are 65 years of age or older, as well as certain younger people with
disabilities
▪Shift towards value-based care has been a significant trend in Hong Kong healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care
38.9% 37.1% 35.6% 32.5% 31.5%
44.0%
46.0% 47.7%
51.0% 51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx
xx xx
xx xx
2019 2020 2021 2022 2023
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative
6.2 Reimbursement Scenario in Hong Kong
42 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
The reimbursement process in Hong Kong healthcare system can be complex and can vary depending on the type of healthcare
service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative
6.3 Reimbursement Process
The reimbursement process in Hong Kong healthcare system can be complex and can vary depending on the type of healthcare
service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative
6.3 Reimbursement Process
43 A Sample Report on Hong Kong Artificial Intelligence (AI) in Diagnostics Market Analysis I Confidential
The reimbursement process in Hong Kong healthcare system can be
complex and can vary depending on the type of healthcare service, the
healthcare provider, and the insurance coverage. Here are the general
steps involved in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
MoH
Private Payers Public Payers
Health Technology Assessment
PaymentCoverageCoding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 32
Illustrative
6.3 Reimbursement Process (Continued)
The reimbursement process in Hong Kong healthcare system can be
complex and can vary depending on the type of healthcare service, the
healthcare provider, and the insurance coverage. Here are the general
steps involved in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
MoH
Private Payers Public Payers
Health Technology Assessment
PaymentCoverageCoding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 32
Illustrative
6.3 Reimbursement Process (Continued)
A division of
Life-sciences Market Research
Reports you can trust
www. insig hts10. com
www.insights10.com
We maintain an extensive database comprising
over 30,000 syndicated market research reports
within the pharmaceuticals and healthcare sector,
offering a global, regional, and country-level
perspective. Our services also include the provision
of customized research reports, meticulously
tailored to align with your specific requirements.
Reports you can trust
www. insig hts10. com
www.insights10.com
We maintain an extensive database comprising
over 30,000 syndicated market research reports
within the pharmaceuticals and healthcare sector,
offering a global, regional, and country-level
perspective. Our services also include the provision
of customized research reports, meticulously
tailored to align with your specific requirements.
At Insights10, our extensive report
library spans a diverse range of
categories within the field of life
sciences.
Market Research
Reports across various
categories in healthcare
www. insig hts10. com
www.insights10.com
Digital
Health
Medical
Devices
Healthcare
Services
Rare
Diseases
Clinical
Trials
OTC &
Nutraceuticals
Pharma
(Diseases
& Drugs)
library spans a diverse range of
categories within the field of life
sciences.
Market Research
Reports across various
categories in healthcare
www. insig hts10. com
www.insights10.com
Digital
Health
Medical
Devices
Healthcare
Services
Rare
Diseases
Clinical
Trials
OTC &
Nutraceuticals
Pharma
(Diseases
& Drugs)
Click on the country to see the reports
available
Global Coverage
North America
•US
•Canada
Latin America
•Brazil
•Argentina
•Mexico
•Ecuador
•Venezuela
•Senegal
Europe
•UK
•Germany
•France
•Italy
•Spain
•Russia
•Netherlands
•Sweden
•Romania
•Switzerland
• Poland
• Austria
• Ireland
• Norway
• Denmark
• Belgium
• Portugal
• Ukraine
• Bulgaria
• Finland
APAC
• India
• China
• South Korea
• Japan
• Australia
• Indonesia
• Hong Kong
• New Zealand
• Philippines
• Singapore
• Malaysia
• Thailand
• Vietnam
Middle East
•UAE
•Saudi Arabia
•Turkey
•Lebanon
•Kuwait
•Qatar
Africa
•Egypt
•Kenya
•South Africa
•Algeria
•Nigeria
•Libya
•Tanzania
•Morocco
available
Global Coverage
North America
•US
•Canada
Latin America
•Brazil
•Argentina
•Mexico
•Ecuador
•Venezuela
•Senegal
Europe
•UK
•Germany
•France
•Italy
•Spain
•Russia
•Netherlands
•Sweden
•Romania
•Switzerland
• Poland
• Austria
• Ireland
• Norway
• Denmark
• Belgium
• Portugal
• Ukraine
• Bulgaria
• Finland
APAC
• India
• China
• South Korea
• Japan
• Australia
• Indonesia
• Hong Kong
• New Zealand
• Philippines
• Singapore
• Malaysia
• Thailand
• Vietnam
Middle East
•UAE
•Saudi Arabia
•Turkey
•Lebanon
•Kuwait
•Qatar
Africa
•Egypt
•Kenya
•South Africa
•Algeria
•Nigeria
•Libya
•Tanzania
•Morocco
What do our reports cover?
Market Overview
Growth Drivers & Growth Restraints
Epidemiology & Disease type
Market Size & Forecast
Competitive Landscape
Policy & Regulatory Landscape
Reimbursement Scenario
Recent Developments
Market Segmentation Factors Driving Future Growth
1
2
3
4
5
6
7
8
9
10
Market Overview
Growth Drivers & Growth Restraints
Epidemiology & Disease type
Market Size & Forecast
Competitive Landscape
Policy & Regulatory Landscape
Reimbursement Scenario
Recent Developments
Market Segmentation Factors Driving Future Growth
1
2
3
4
5
6
7
8
9
10
01 0302 04 05
Define
precise
research
questions
Validate data
through primary
research
interviews
Gather data
through
secondary
research
Forecast
market size
and segment
analysis
Extract key
insights from
the research
findings
06
Compile &
present a
comprehensive
analytical report
Our Research Process
Define
precise
research
questions
Validate data
through primary
research
interviews
Gather data
through
secondary
research
Forecast
market size
and segment
analysis
Extract key
insights from
the research
findings
06
Compile &
present a
comprehensive
analytical report
Our Research Process
Bottom Up Approach
Analyze product or treatment pricing
and reimbursement strategies
Evaluate consumer or patient
demographics and numbers
Predict future market
growth or decline based
on key market trends &
dynamics
Find
final
market size
Top Down Approach
Examine the total healthcare expenditure in
the targeted disease or service domain.
Assess the proportion of spending
allocated to the specific product or
treatment category.
Predict future market
growth or decline
based on key market
trends & dynamics
Find
final
market
size
Data Triangulation & Data Validation
Analyze product or treatment pricing
and reimbursement strategies
Evaluate consumer or patient
demographics and numbers
Predict future market
growth or decline based
on key market trends &
dynamics
Find
final
market size
Top Down Approach
Examine the total healthcare expenditure in
the targeted disease or service domain.
Assess the proportion of spending
allocated to the specific product or
treatment category.
Predict future market
growth or decline
based on key market
trends & dynamics
Find
final
market
size
Data Triangulation & Data Validation
2023
2024-
2030
Report Attribute
Quantitative Units
Pricing and Purchase
Revenue in USD Million/Bn (Mn/Bn)
Our pricing and purchase options are adaptable to
suit the specific scope of work.
Details Time Frame
Base
Year for
estimation
Forecast
Period
Report Scope
Delivery Timeline
Typically, the delivery of the final report falls within a
timeframe of 5 to 7 business days, but the exact
duration may vary depending on the project's scope.
Customization
We are pleased to offer you the option of
customizing the report to align with your specific
research requirements at no extra charge, provided
it falls within the defined scope of the project.
2024-
2030
Report Attribute
Quantitative Units
Pricing and Purchase
Revenue in USD Million/Bn (Mn/Bn)
Our pricing and purchase options are adaptable to
suit the specific scope of work.
Details Time Frame
Base
Year for
estimation
Forecast
Period
Report Scope
Delivery Timeline
Typically, the delivery of the final report falls within a
timeframe of 5 to 7 business days, but the exact
duration may vary depending on the project's scope.
Customization
We are pleased to offer you the option of
customizing the report to align with your specific
research requirements at no extra charge, provided
it falls within the defined scope of the project.
We have access to a multitude of highly
dependable data sources, supported by
years of experience that guide us in
discerning which sources are most reliable
and current for the specific information
needed.
Access to credible
data sources for
secondary research
www. insig hts10. com
www.insights10.com
Statistical
Databases
Annual
Reports
Trade
Publications
Online
Databases
Published
Research
Reports
White-
papers
Press
Releases
dependable data sources, supported by
years of experience that guide us in
discerning which sources are most reliable
and current for the specific information
needed.
Access to credible
data sources for
secondary research
www. insig hts10. com
www.insights10.com
Statistical
Databases
Annual
Reports
Trade
Publications
Online
Databases
Published
Research
Reports
White-
papers
Press
Releases
Reliable
Expert Verified
Realistic
Comprehensive
Easy to read
Our reports present data, which is
The report is prepared using a proven methodology and insightful
research
The report is prepared by a team of highly qualified & experienced
research analysts & vetted by our local associates
The report allows you to confidently make smarter business and
strategic decisions based on realistic findings
Covers everything you would need to know about the market
including market size, competitive analysis & much more
You do not have to be a market expert to understand what really is
happening on the market and how it works
Expert Verified
Realistic
Comprehensive
Easy to read
Our reports present data, which is
The report is prepared using a proven methodology and insightful
research
The report is prepared by a team of highly qualified & experienced
research analysts & vetted by our local associates
The report allows you to confidently make smarter business and
strategic decisions based on realistic findings
Covers everything you would need to know about the market
including market size, competitive analysis & much more
You do not have to be a market expert to understand what really is
happening on the market and how it works
Yearly Access
(Subscription)
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database Service
& KOL Mapping
Primary Research &
Interviews
Customized Market
Research Reports
Syndicated Market
Research Reports
Our Services
(Subscription)
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database Service
& KOL Mapping
Primary Research &
Interviews
Customized Market
Research Reports
Syndicated Market
Research Reports
Our Services
“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market. We at
Insights10 are building the future of market research and
are committed to providing our clients with the right
intelligence and insights to make business decisions
quickly and efficiently.
Insights10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working with
some of the best organizations in the world, generating
insights that provides substantial competitive advantage.”
Dr. Purav Gandhi, Founder & CEO
Click to watch Our Introductory Video here
CEO Speaks
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market. We at
Insights10 are building the future of market research and
are committed to providing our clients with the right
intelligence and insights to make business decisions
quickly and efficiently.
Insights10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working with
some of the best organizations in the world, generating
insights that provides substantial competitive advantage.”
Dr. Purav Gandhi, Founder & CEO
Click to watch Our Introductory Video here
CEO Speaks
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of
experience in management
consulting in the Life Sciences
sector, and has worked with
diverse multinational firms in
the US, India, Middle East and
APAC regions. His primary area
of interest is Customer and
Market Strategy, Market
Access, and Digital Health with
special focus on emerging
markets like Africa, Middle East
and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research &
marketing professional with a
progressive experience of over 20
years in Life Sciences, Healthcare
services, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager
Leadership Team
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of
experience in management
consulting in the Life Sciences
sector, and has worked with
diverse multinational firms in
the US, India, Middle East and
APAC regions. His primary area
of interest is Customer and
Market Strategy, Market
Access, and Digital Health with
special focus on emerging
markets like Africa, Middle East
and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research &
marketing professional with a
progressive experience of over 20
years in Life Sciences, Healthcare
services, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager
Leadership Team
@Our Team
@Work
Beyond Work
… and many more
Pi-SM
GmbH
Our Clients
Pi-SM
GmbH
Our Clients
I've had the pleasure of availing Insights10’s services several times, and I've always
been impressed by their expertise, professionalism, and dedication to providing us with
the highest quality data and insights. Whether one is looking to launch a new product,
expand into a new market, or better understand one's target customers, Insights10
insures achieving the goals.
Their team of experts has a deep understanding of the healthcare industry, and they use
their knowledge to develop customized research solutions that meet the specific needs
of each client. I highly recommend Insights10 to anyone looking for a reliable and
experienced partner in healthcare market research. They're a valuable asset to any
company that wants to succeed in this dynamic sector.
Sid Panigrahy
Founder-CEO, MediGlobo Inc.,
(Healthcare - Group Company of Omi Holdings, Inc) Tampa, Florida (USA)
What our clients say
been impressed by their expertise, professionalism, and dedication to providing us with
the highest quality data and insights. Whether one is looking to launch a new product,
expand into a new market, or better understand one's target customers, Insights10
insures achieving the goals.
Their team of experts has a deep understanding of the healthcare industry, and they use
their knowledge to develop customized research solutions that meet the specific needs
of each client. I highly recommend Insights10 to anyone looking for a reliable and
experienced partner in healthcare market research. They're a valuable asset to any
company that wants to succeed in this dynamic sector.
Sid Panigrahy
Founder-CEO, MediGlobo Inc.,
(Healthcare - Group Company of Omi Holdings, Inc) Tampa, Florida (USA)
What our clients say
Dear Insights10 Team, I wanted to thank you all for the great work you conducted
producing the Kenya Medical and Diagnostic Laboratory Service Market Analysis. The
quality of the report was excellent, and you managed to complete it in record time. I was
also impressed by your quick turnaround on the topics discussed as a follow up after the
report's first version; you managed to gather the information required, plus a very good
analysis.
I will definitely consider working with you again if the opportunity arises, and will not
hesitate in recommending you to colleagues working in the field Thank you again for
your professionalism and team work. It was a pleasure working with you.
Lelio Marmora
CEO, The Management Lab, Geneva
Ex. Executive Director, UNITAID
What our clients say
producing the Kenya Medical and Diagnostic Laboratory Service Market Analysis. The
quality of the report was excellent, and you managed to complete it in record time. I was
also impressed by your quick turnaround on the topics discussed as a follow up after the
report's first version; you managed to gather the information required, plus a very good
analysis.
I will definitely consider working with you again if the opportunity arises, and will not
hesitate in recommending you to colleagues working in the field Thank you again for
your professionalism and team work. It was a pleasure working with you.
Lelio Marmora
CEO, The Management Lab, Geneva
Ex. Executive Director, UNITAID
What our clients say
Michael Blumberg Youssef Mallat
Wissem Menad
Dr. Robert Ryan
Co Founder GFAU Pty Ltd., Australia
Co Founder – Embi, Optimum Oral care, Australia
Opusline, A part of Accenture, Paris
Senior Manager Segment Marketing
Performance Health,London, UK
Chief Executive Officer, Innova Therapeutics, Inc., USA
We engaged INSIGHTS10 to assist us with our research requirements
for the Oral Care Market sector in Australia. We been very impressed
with the depth and quality of data and equally with the personal
service we experience from the management team on our account.
They understand our business, our challenges and our goals. There is
a real sense of partnership as we continue to work together.
The info you delivered on the European Patient
Support Market with a deep dive into countries
like Spain, Germany, Italy, France, UK and
Belgium, was very useful.
Insights10 has been a great resource for
getting a detailed report on the UK
Physiotherapy Market. Usually I had multiple
sources for getting global reports, but now I
can get in-depth country reports from
Insights10 which has been a game changer.
We were looking for very specific information regarding Abu Dhabi
Oncology Drugs Market. The insights provided by Insights10 is
fantastic and they just took less than three days to deliver the report.
What our clients say
Wissem Menad
Dr. Robert Ryan
Co Founder GFAU Pty Ltd., Australia
Co Founder – Embi, Optimum Oral care, Australia
Opusline, A part of Accenture, Paris
Senior Manager Segment Marketing
Performance Health,London, UK
Chief Executive Officer, Innova Therapeutics, Inc., USA
We engaged INSIGHTS10 to assist us with our research requirements
for the Oral Care Market sector in Australia. We been very impressed
with the depth and quality of data and equally with the personal
service we experience from the management team on our account.
They understand our business, our challenges and our goals. There is
a real sense of partnership as we continue to work together.
The info you delivered on the European Patient
Support Market with a deep dive into countries
like Spain, Germany, Italy, France, UK and
Belgium, was very useful.
Insights10 has been a great resource for
getting a detailed report on the UK
Physiotherapy Market. Usually I had multiple
sources for getting global reports, but now I
can get in-depth country reports from
Insights10 which has been a game changer.
We were looking for very specific information regarding Abu Dhabi
Oncology Drugs Market. The insights provided by Insights10 is
fantastic and they just took less than three days to deliver the report.
What our clients say
Thank You
www. insig hts10. com
www.insights10.com
Email: [email protected]
India: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?
www. insig hts10. com
www.insights10.com
Email: [email protected]
India: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?
Download
Download Slideshow Get the original presentation fileQuick Actions
Statistics
- Views 58
- Slides 64
- Age 481 days
Related Slideshows
11
8-top-ai-courses-for-customer-support-representatives-in-2025.pptx
JeroenErne2
45 views
10
7-essential-ai-courses-for-call-center-supervisors-in-2025.pptx
JeroenErne2
45 views
13
25-essential-ai-courses-for-user-support-specialists-in-2025.pptx
JeroenErne2
36 views
11
8-essential-ai-courses-for-insurance-customer-service-representatives-in-2025.pptx
JeroenErne2
33 views
21
Know for Certain
DaveSinNM
19 views
17
PPT OPD LES 3ertt4t4tqqqe23e3e3rq2qq232.pptx
novasedanayoga46
23 views